Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$70.43 - $97.42 $4.16 Million - $5.75 Million
-59,009 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$48.9 - $75.26 $2.89 Million - $4.44 Million
59,009 New
59,009 $4.44 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.45B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Caisse De Depot Et Placement Du Quebec Portfolio

Follow Caisse De Depot Et Placement Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.